10-Q Filing

Talkspace, Inc. CIK: 1803901 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-004641`
Period End Date	20210930
Filing Date	20211115
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	talk-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 82 Cash Flow Statement 60 Stockholders Equity 48

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$222.87M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.32M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.91M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$10.02M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$238.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.68M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$175.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$658.00K	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	-	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	$692.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.88M	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$82.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	129.40M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	152.29M	shares	Point-in-time
Total assets	`Assets`	$248.96M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.41M	shares	Point-in-time
Total assets	`Assets`	$32.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.29M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.04M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$5.17M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$8.30M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$7.42M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$7.63M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$29.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.49M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	$12.01M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$86.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$42.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.49M	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of $0.0001 par value - Authorized: 100,000,000 and 95,709,146 shares at September 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at September 30, 2021 and December 31, 2020, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	-	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of $0.0001 par value - Authorized: 100,000,000 and 95,709,146 shares at September 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at September 30, 2021 and December 31, 2020, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$111.28M	USD	Point-in-time
Common stock of 0.0001 par value -- Authorized: 1,000,000,000 and 129,397,278 shares at September 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 152,293,298 and 13,413,431 shares at September 30, 2021 and December 31, 2020, respectively (1)	`CommonStockValue`	$15.00K	USD	Point-in-time
Common stock of 0.0001 par value -- Authorized: 1,000,000,000 and 129,397,278 shares at September 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 152,293,298 and 13,413,431 shares at September 30, 2021 and December 31, 2020, respectively (1)	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$357.33M	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$9.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-150.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-108.79M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$206.88M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$202.26M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' (deficit)	`LiabilitiesAndStockholdersEquity`	$32.87M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' (deficit)	`LiabilitiesAndStockholdersEquity`	$248.96M	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	Point-in-time
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$84.50M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$21.50M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.50M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$26.36M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$33.70M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$6.41M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$17.39M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$12.19M	USD	1 Quarter
Gross profit	`GrossProfit`	$14.17M	USD	1 Quarter
Gross profit	`GrossProfit`	$15.09M	USD	1 Quarter
Gross profit	`GrossProfit`	$33.11M	USD	3 Qtrs
Gross profit	`GrossProfit`	$50.80M	USD	3 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$12.02M	USD	3 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$2.20M	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$7.33M	USD	3 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$4.28M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$899.00K	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$5.89M	USD	3 Qtrs
Clinical operations	`OtherCostAndExpenseOperating`	$1.90M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$2.54M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$30.02M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$12.66M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$26.43M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$75.12M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.20M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$23.11M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.74M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$39.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$116.15M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$17.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$44.08M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$25.23M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$10.97M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$2.40M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$65.34M	USD	3 Qtrs
Financial income (expense), net	`InterestAndDebtExpenseIncome`	$23.70M	USD	3 Qtrs
Financial income (expense), net	`InterestAndDebtExpenseIncome`	$26.74M	USD	1 Quarter
Financial income (expense), net	`InterestAndDebtExpenseIncome`	$-254.00K	USD	3 Qtrs
Financial income (expense), net	`InterestAndDebtExpenseIncome`	$-285.00K	USD	1 Quarter
Income (Loss) before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$41.65M	USD	3 Qtrs
Income (Loss) before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.52M	USD	1 Quarter
Income (Loss) before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.69M	USD	1 Quarter
Income (Loss) before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$11.23M	USD	3 Qtrs
Taxes on income	`IncomeTaxExpenseBenefit`	$11.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$29.00K	USD	3 Qtrs
Taxes on income	`IncomeTaxExpenseBenefit`	$3.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$12.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.67M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-11.24M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.50M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$41.67M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-1.50M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$11.24M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.69M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.84	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.64	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.84	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.64	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.35M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	64.64M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	152.27M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.38M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	64.64M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.35M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.38M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	165.18M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.67M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-11.24M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$1.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.46M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$55.00K	USD	3 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$175.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$20.58M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.07M	USD	3 Qtrs
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	-	USD	3 Qtrs
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	$23.84M	USD	3 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-596.00K	USD	3 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.04M	USD	3 Qtrs
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.11M	USD	3 Qtrs
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$8.52M	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.02M	USD	3 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.11M	USD	3 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-3.39M	USD	3 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-3.13M	USD	3 Qtrs
(Decrease) increase in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.19M	USD	3 Qtrs
(Decrease) increase in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-134.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.11M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.66M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$43.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$622.00K	USD	3 Qtrs
Proceeds from restricted long-term bank deposit	`ProceedsFromRestrictedLongTermBankDeposit`	-	USD	3 Qtrs
Proceeds from restricted long-term bank deposit	`ProceedsFromRestrictedLongTermBankDeposit`	$414.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$371.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-622.00K	USD	3 Qtrs
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	-	USD	3 Qtrs
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	$249.43M	USD	3 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	$6.00M	USD	3 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	-	USD	3 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	$6.00M	USD	3 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	-	USD	3 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$50.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.97M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$62.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$62.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$251.35M	USD	3 Qtrs
Change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$209.62M	USD	3 Qtrs
Change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.23M	USD	3 Qtrs
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$33.40M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$222.87M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$33.40M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$222.87M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$29.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$115.00K	USD	3 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	$111.28M	USD	3 Qtrs

Stockholders Equity 48 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$206.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.29M	shares	Point-in-time
Common stock issued related to exercise of warrants, value	`StockIssuedDuringPeriodValueWarrants`	$609.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodSharesStockOptionsExercised`	3.34M	shares	3 Qtrs
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.13M	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$45.00K	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$797.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.51M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.88M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$401.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$332.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$336.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.20M	USD	1 Quarter
Preferred stock conversion, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$111.28M	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$125.00K	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$27.95M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.69M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.67M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-11.24M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$1.50M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$206.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.29M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.